MedTrace Logo

The Effect of Solifenacin Used for Lower Urinary Tract Symptoms on Sexual Function

NCT05391425 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-05-26

No results posted yet for this study

Summary

This study aims to determine whether Solifenacine used for lower urinary tract symptoms improves sexual function and if so does this improvement differs between premenopausal and postmenopausal women.

Conditions

  • Urge Incontinence
  • Urgency-frequency Syndrome

Interventions

OTHER

no intervention

no intervention planned, since it is an observational study

Sponsors & Collaborators

  • Arnavutkoy State Hospital

    collaborator OTHER

  • Istanbul University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-03
Primary Completion
2023-06-03
Completion
2024-06-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05391425 on ClinicalTrials.gov